Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

BACKGROUND: Metronomic oral vinorelbine could be a safe option for elderly patients with advanced non small cell lung cancer (NSCLC). Metronomic administration of chemotherapy leads to a cytostatic action shifting treatment target from cancer cell to tumor angiogenesis. METHODS: 43 chemotherapy naiv...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Camerini, Andrea, Puccetti, Cheti, Donati, Sara, Valsuani, Chiara, Petrella, Maria Cristina, Tartarelli, Gianna, Puccinelli, Paolo, Amoroso, Domenico
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4424528/
https://ncbi.nlm.nih.gov/pubmed/25943747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1354-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi